Laurion Capital Management LP Invests $370,000 in The Clorox Company (NYSE:CLX)

Laurion Capital Management LP bought a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,281 shares of the company's stock, valued at approximately $370,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. Brooklyn Investment Group raised its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new stake in Clorox during the 4th quarter valued at $26,000. Millstone Evans Group LLC bought a new stake in Clorox during the 4th quarter valued at $31,000. Asset Planning Inc bought a new stake in Clorox during the 4th quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. bought a new position in shares of Clorox in the 4th quarter worth $32,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 1.0%

NYSE:CLX traded up $1.32 during mid-day trading on Friday, hitting $136.31. 3,182,936 shares of the company's stock traded hands, compared to its average volume of 1,321,018. The company has a fifty day moving average of $141.05 and a 200 day moving average of $153.32. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a market capitalization of $16.80 billion, a P/E ratio of 37.24, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The firm's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.71 EPS. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were paid a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.58%. Clorox's payout ratio is presently 87.61%.

Analysts Set New Price Targets

CLX has been the subject of several recent research reports. DA Davidson reduced their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. UBS Group reduced their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Wells Fargo & Company reduced their price target on Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Barclays reduced their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research report on Wednesday, May 7th. Finally, Evercore ISI set a $140.00 price target on Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $151.23.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now owns 4,000 shares in the company, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.57% of the company's stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.